MTOR and Insulin resistance: Although the kinase activity of MTOR in MTORC2 is insensitive to acute rapamycin treatment, chronic exposure to the drug can disrupt its structure and results in insulin resistance (Sarbassov et al. 2006; Ye et al. 2012).